Mega Cap Healthcare
Stocks Ranked by
Market Capitalization
| Name | Market cap | Price |
Price change % |
|
|---|---|---|---|---|
1
Eli Lilly
LLY
$1.27T
| $1.27T | $1,421.09 | 0.83% |
|
2
Johnson & Johnson
JNJ
$656B
| $656B | $272.71 | 2.46% |
|
3
AbbVie
ABBV
$504B
| $504B | $285.47 | 0.19% |
|
4
Merck
MRK
$366B
| $366B | $148.30 | 2.51% |
|
5
UnitedHealth
UNH
$362B
| $362B | $403.01 | 0.35% |
|
6
Novartis
NVS
$308B
| $308B | $163.31 | 2.54% |
|
7
AstraZeneca
AZN
$293B
| $293B | $188.64 | 2.59% |
|
8
Thermo Fisher Scientific
TMO
$258B
| $258B | $696.14 | 0.32% |
|
9
Amgen
AMGN
$256B
| $256B | $474.19 | 2.8% |
|
10
Gilead Sciences
GILD
$213B
| $213B | $171.99 | 2.7% |
|
Mega Cap Healthcare Stocks at a Glance
Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.
There are 10 mega cap Healthcare stocks — companies in the Healthcare sector with a market cap over $200B — worth a combined $4.48T.
The largest by market cap are Eli Lilly (LLY) at $1.27T, Johnson & Johnson (JNJ) at $656B and AbbVie (ABBV) at $504B.
Among institutional investors, UnitedHealth (UNH) drew the most net new fund positions in Q2 2026: 531 funds opened new positions, taking total fund holders up 348 (11%) quarter-over-quarter.
- Combined market cap: $4.48T across 10 stocks.
- Mega Cap: market cap over $200B.
- Largest constituent: Eli Lilly (LLY), $1.27T market cap.
- Most net new fund positions in Q2 2026: UnitedHealth (UNH), +348 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.